Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Immunoglobulin heavy diversity 5-5 (IGHD5-5) is one of several "diversity" (D) gene segments within the human immunoglobulin heavy chain (IGH) locus located on chromosome 14q32[1]. During B-cell development, IGHD segments—including IGHD5-5—are selected and recombined, along with variable (V) and joining (J) segments, to assemble the variable region of the immunoglobulin heavy chain. This process, called V(D)J recombination, is crucial for generating the diverse repertoire of antibodies necessary for immune defense[2]. IGHD segments do not encode proteins themselves but act as DNA templates contributing diversity to the third hypervariable region (CDR3) of the antibody antigen-binding site. There are multiple IGHD gene segments, and disruptions or polymorphisms in these segments can influence immune repertoire diversity but are not typically direct disease targets.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immunoglobulin heavy diversity 5-5 gene segment (IGHD5-5).